Overview

Biotech Square is using artificial intelligence to address knowledge gaps in drug development. Our first platform, Regulatory Foresight, is used by biopharmaceutical companies to answer the most challenging questions on precedent. Using natural language processing and machine learning, documents released by the regulatory agencies (FDA, EMA and Health Canada) are made accessible to allow drug development teams to learn from past development strategies, sponsor-agency interactions, study designs, endpoint selection, product formulation and more.